Watson Pharmaceuticals promoted Thomas Russillo to act as head of its newly formed global generics commercial function. As EVP, global generics, Russillo will have responsibility for US and Canadian generic sales and marketing, as well as for all international markets to be added following Watson’s acquisition of Arrow Group. Russillo had been EVP and president of the Generics Division.